Sclerostin as a Putative Myokine in Sarcopenia
- PMID: 35798549
- PMCID: PMC9262685
- DOI: 10.3803/EnM.2022.303
Sclerostin as a Putative Myokine in Sarcopenia
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
References
-
- Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19:179–92. - PubMed
-
- Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D’Agostin D, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008;23:860–9. - PubMed
-
- Nga HT, Jang IY, Kim DA, Park SJ, Lee JY, Lee S, et al. Serum GDF15 level is independent of sarcopenia in older Asian adults. Gerontology. 2021;67:525–31. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
